DXCM241206C100000
- 0.01
- 0.000.00%
DexCom Newsroom
Unusual Options Activity: PINS, MCHP and Others Attract Market Bets, PINS V/OI Ratio Reaches 333.3
EST Dec 3rd Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
The annual "big reshuffling" of the Nasdaq 100 is about to begin! Who is expected to join, and who will be eliminated?
This year's potential high-flying stocks like palantir, MSTR and more are expected to be included.
United States Diabetes Device Market Forecast Report and Company Analysis 2024-2032 Featuring BD, Roche, Medtronic, Insulet, Abbott, Dexcom, Tandem Diabetes Care, Ypsomed Novo Nordisk, Eli Lilly - ResearchAndMarkets.com
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
The Return Trends At DexCom (NASDAQ:DXCM) Look Promising
Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Express News | Dexcom Inc : Leerink Partners Cuts Target Price to $86 From $87
Dexcom's G7 Hospital CGM Poised for Market Breakthrough With NTAP and FDA Approvals
Here's Why DexCom (DXCM) Declined In Q3
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Wells Fargo Sticks to Its Buy Rating for Dexcom (DXCM)
These 10 Laggard Stocks Could Get Hit Further by Tax-Loss Selling
DexCom Pairs Its Glucose Monitor With Oura's Smart Ring -- Barrons.com
DexCom, ŌURA Enter Strategic Partnership; Dexcom Is Investing $75M In Ōura Series D Funding
Oura Valued at $5 Billion in Deal With Glucose Device Maker Dexcom
Dexcom and ŌURA Announce Strategic Partnership